相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5-Year Data From the Phase 3 Long-Term Odanacatib Fracture Trial (LOFT) and its Extension
Robert Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases
Lingxin Zhu et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Osteoclasts Provide Coupling Signals to Osteoblast Lineage Cells Through Multiple Mechanisms
Natalie A. Sims et al.
Annual Review of Physiology (2019)
Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss
Jinhu Xiong et al.
NATURE COMMUNICATIONS (2018)
Coupling of bone resorption and formation by RANKL reverse signalling
Yuki Ikebuchi et al.
NATURE (2018)
Discovery of a periosteal stem cell mediating intramembranous bone formation
Shawon Debnath et al.
NATURE (2018)
Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned
Matthew T. Drake et al.
ENDOCRINE REVIEWS (2017)
Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro
Harry C. Blair et al.
TISSUE ENGINEERING PART B-REVIEWS (2017)
Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate
Yi Fan et al.
CELL METABOLISM (2017)
Chondrocytic ephrin B2 promotes cartilage destruction by osteoclasts in endochondral ossification
Stephen Tonna et al.
DEVELOPMENT (2016)
Merck & Co. drops osteoporosis drug odanacatib
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
Osteocytic signalling pathways as therapeutic targets for bone fragility
Lilian I. Plotkin et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis
Bente Langdahl et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2016)
Osteoblast-induced osteoclast apoptosis by fas ligand/FAS pathway is required for maintenance of bone mass
L. Wang et al.
CELL DEATH AND DIFFERENTIATION (2015)
Parathyroid hormone: anabolic and catabolic actions on the skeleton
Barbara C. Silva et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Secondary osteoporosis: pathophysiology and management
Faryal Mirza et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship
Boris Hinz
MATRIX BIOLOGY (2015)
EphrinB2 signaling in osteoblasts promotes bone mineralization by preventing apoptosis
Stephen Tonna et al.
FASEB JOURNAL (2014)
Osteoclast-Derived Complement Component 3a Stimulates Osteoblast Differentiation
Kazuhiko Matsuoka et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures
Sofia Moverare-Skrtic et al.
NATURE MEDICINE (2014)
Osteoclasts: more than 'bone eaters'
Julia F. Charles et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Semaphorin 3A A new player in bone remodeling
Ren Xu
CELL ADHESION & MIGRATION (2014)
Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib
Natalie A. Sims et al.
CURRENT OSTEOPOROSIS REPORTS (2014)
Understanding Coupling between Bone Resorption and Formation Are Reversal Cells the Missing Link?
Thomas L. Andersen et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Meta-analysis of genome-wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women
Daniel L. Koller et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone
Farzin M. Takyar et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation
Sutada Lotinun et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation
Sunao Takeshita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Sema3A regulates bone-mass accrual through sensory innervations
Toru Fukuda et al.
NATURE (2013)
Clinical targeting of the TNF and TNFR superfamilies
Michael Croft et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Osteopetrosis: genetics, treatment and new insights into osteoclast function
Cristina Sobacchi et al.
NATURE REVIEWS ENDOCRINOLOGY (2013)
Osteoprotection by semaphorin 3A
Mikihito Hayashi et al.
NATURE (2012)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture
Karol Estrada et al.
NATURE GENETICS (2012)
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
Lingling Xian et al.
NATURE MEDICINE (2012)
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis
Kazuhiro Maeda et al.
NATURE MEDICINE (2012)
Building strong bones: molecular regulation of the osteoblast lineage
Fanxin Long
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Estrogen and the skeleton
Sundeep Khosla et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Meta-Analysis of Genome-Wide Scans for Total Body BMD in Children and Adults Reveals Allelic Heterogeneity and Age-Specific Effects at the WNT16 Locus
Carolina Medina-Gomez et al.
PLOS GENETICS (2012)
Disorders of Bone Remodeling
Xu Feng et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Bone remodelling at a glance
Julie C. Crockett et al.
JOURNAL OF CELL SCIENCE (2011)
Targeting osteoclast-osteoblast communication
Xu Cao
NATURE MEDICINE (2011)
Matrix-embedded cells control osteoclast formation
Jinhu Xiong et al.
NATURE MEDICINE (2011)
Suppression of bone formation by osteoclastic expression of semaphorin 4D
Takako Negishi-Koga et al.
NATURE MEDICINE (2011)
Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
Aline G. Costa et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011
Yang Xue et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Genetic Control of Bone Formation
Gerard Karsenty et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2009)
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
Masaru Ishii et al.
NATURE (2009)
TGF-β1-induced migration of bone mesenchymal stem cells couples bone resorption with formation
Yi Tang et al.
NATURE MEDICINE (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Normal Bone Anatomy and Physiology
Bart Clarke
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival
Susan A. Krum et al.
EMBO JOURNAL (2008)
Control of Bone Mass and Remodeling by PTH Receptor Signaling in Osteocytes
Charles A. O'Brien et al.
PLOS ONE (2008)
Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate
Larry Pederson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Wnt10b increases postnatal bone formation by enhancing osteoblast differentiation
Christina N. Bennett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
B cells and T cells are critical for the preservation of bone hon-leostasis and attainment of peak bone mass in vivo
Yan Li et al.
BLOOD (2007)
The molecular understanding of osteoclast differentiation
Masataka Asagiri et al.
BONE (2007)
Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling
Jiyoon Ryu et al.
EMBO JOURNAL (2006)
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Chen Zhao et al.
CELL METABOLISM (2006)
Denosumab in postmenopausal women with low bone mineral density
MR McClung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Regulation of osteoblastogenesis and bone mass by Wnt10b
CN Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Clinical case seminar - Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis
N Fratzl-Zelman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling
S Theoleyre et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women
PJ Bekker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
The Wnt signaling pathway in development and disease
CY Logan et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY (2004)
Control of osteoblast function and regulation of bone mass
S Harada et al.
NATURE (2003)
Osteoclast differentiation and activation
WJ Boyle et al.
NATURE (2003)
Mechanisms and functions of EPH and ephrin signalling
K Kullander et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation
V Everts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosis
A Mizuno et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2002)
The role of Fas ligand in immune privilege
DR Green et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism
J Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
